Does the onset of tuberculosis in AIDS predict shorter survival? Results of a cohort study in 17 European countries over 13 years

BMJ

Volumn 311, Issue 7018, 1995, Pages 1468-

  Perneger, Thomas V ^a   Sudre, Philippe ^b   Lundgren, Jens D ^c   Hirschel, Bernard ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TUBERCULOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COHORT STUDIES; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMAN; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS; SURVIVAL RATE; TUBERCULOSIS;

EID: 0028973502     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.311.7018.1468     Document Type: Article

References (15)

1. Horsburgh CR Pozniak A. Epidemiology of tuberculosis in the era of HIV. AIDS 1993; 7(suppl 1):S109–14.
2. Braun MM Cote TR Rabkin CS. Trends in death with tuberculosis during the AIDS era. JAMA 1993; 269: 2865–8.
3. Ackah AN Coulibaly D Digbeu H Diallo K Vetter KM Coulibaly IM, et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote d'Ivoire. Lancet 1995; 345: 607–10.
4. Chaisson RE Schecter GF Theuer CP Rutherford GW Echenberg DF Hopewell PC. Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis 1987; 136: 570–4.
5. Chequer P Hearst N Hudes ES Castilho E Rutherford G Loures L, et al. Determinants of survival in adult Brazilian AIDS patients, 1982–1989. AIDS 1992; 6: 483–7.
6. Buira E Gatell JM Miro JM Batalla J Zamora L Mallolas J, et al. Influence of treatment with zidovudine (ZDV) on the long-term survival of AIDS patients. Journal of the Acquired Immune Deficiency Syndrome 1992; 5: 737–42.
7. Lundgren JD Pedersen C Clumeck N Gatell JM Johnson AM Ledergerber B, et al. Survival differences in European patients with AIDS, 1979–89. BMJ 1994; 308: 1068–73.
8. Centers for Disease Control. Revision of the CDC case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 1987; 36(suppl):3–15.
9. Collett D. Modelling survival data in medical research. London: Chapman and Hall, 1994.
10. Whalen C Horsburgh CR Hom D Lahart C Simberkoff M Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. American Journal of Respiratory Critical Care Medicine 1995; 151: 129–35.
11. Brudney K Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144: 745–9.
12. Small PM Schecter GF Goodman PC Sande MA Chaisson RE Hopewell PC. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 1991; 324: 289–94.
13. Busillo CP Lessnau KD Sanjana V Soumakis S Davidson M Mullen MP, et al. Multidrug-resistant Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. Chest 1992; 102: 797–801.
14. Wallis RS Vjecha M Amir-Tahmasseb M Okwera A Byekwaso F Nyole S, et al. Influence of Mycobacterium tuberculosis and HIV-1: enhanced cytokine expression and elevated beta-2 microglobulin in HIV-1 associated tuberculosis. J Infect Dis 1993; 167: 43–8.
15. De Cock KM Grant A Porter JDH. Preventive therapy for tuberculosis in HIV-infected persons: international recommendations, research, and practice. Lancet 1995; 345: 833–6.